Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Часто задаваемые вопросы
В каком секторе работает Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)?
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares относится к сектору Промышленность.
Какова текущая цена акций Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)?
По последним данным, цена акций Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares составляет 2,14 $, предыдущее закрытие — 2,19 $. За последнюю торговую сессию акции Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares снизились на -0,05 $, что соответствует падению на -2,28%.
Выплачивает ли Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) дивиденды?
Нет, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)?
У компании Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares бета 0.477, что указывает на более низкую волатильность по сравнению с рынком в целом.
